Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

EDAR, Mouse, Clone: 3A7, Abnova™

Mouse monoclonal antibody raised against a partial recombinant EDAR.

Supplier:  Abnova Corporation H00010913M02A

Catalog No. 89-106-425


Only null left
Add to Cart

Description

Description

This gene encodes a member of the tumor necrosis factor receptor family. The encoded transmembrane protein is a receptor for the soluble ligand ectodysplasin A, and can activate the nuclear factor-kappaB, JNK, and caspase-independent cell death pathways. It is required for the development of hair, teeth, and other ectodermal derivatives. Mutations in this gene result in autosomal dominant and recessive forms of hypohidrotic ectodermal dysplasia. [provided by RefSeq

Sequence: TKDEDYGCVPCPAEKFSKGGYQICRRHKDCEGFFRATVLTPGDMENDAECGPCLPGYYMLENRPRNIYGMVCYSCLLAPPNTKECVGATSGASANFPGTSGSSTLSPFQHAHKEL
Specifications

Specifications

EDAR
Monoclonal
Unconjugated
ascites with no preservative
NM_022336
EDAR
EDAR (NP_071731,64 a.a. ∽ 178 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
RUO
10913
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Ascites
ELISA, Western Blot
3A7
Mouse monoclonal antibody raised against a partial recombinant EDAR.
EDAR
DL/ED1R/ED3/ED5/EDA-A1R/EDA1R/EDA3/FLJ94390
Mouse
200 μL
Primary
Human
Antibody
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.